Lamb Lawrence — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Lamb Lawrence has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Lawrence Lamb is an executive vice president and chief scientific officer at IN8bio, Inc., a clinical-stage biopharmaceutical company. He is involved in the development of innovative therapies targeting solid and liquid tumors using gamma-delta T cells.

Board memberships

• IN8bio, Inc.

Awards & honors

• Leadership in gamma-delta T cell therapy development
• Contributions to clinical-stage biopharmaceutical advancements

Companies — Last 90 Days

• IN8BIO, INC. (INAB) — 1 filings, last 2026-05-12

Frequently Asked Questions

Who is Lamb Lawrence?

Lawrence Lamb is an executive vice president and chief scientific officer at IN8bio, Inc., a clinical-stage biopharmaceutical company. He is involved in the development of innovative therapies targeting solid and liquid tumors using gamma-delta T cells.…

How many SEC Form 4 filings has Lamb Lawrence submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Lamb Lawrence's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week